Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops product candidate for the treatment of rheumatoid arthritis and hyper inflammatory syndrome inflammation related to COVID-19. It also intends to develop product candidate to treat oncology indications. The company is headquartered in Tel Aviv-Jaffa, Israel.